Markets, deals, earnings and the briefings that matter to readers in India.
Business
India has raised the cost of regulatory fraud in drug approvals to its highest level yet — companies that submit fabricated data can now be barred from filing fresh applications entirely, not just…
Seoul's KOSPI shed nearly 4.6% in a single session, erasing two days of AI-optimism gains as Wall Street's overnight chip…
Firstsource Solutions posted a brutal quarter — net profit down 19% sequentially and EBIT margins nearly halved from 24% to 12.4%…
India's Nifty 50 TRI lost 0.4% over the year to June 2026 while South Korea's Kospi surged 103%. But Abakkus Investment Managers…
India's largest-ever public offering just closed — and it wasn't a startup or a tech giant. The government's LIC OFS raised…
Bank of Baroda's latest report puts India's July 2026 CPI at 4.5%, but the real alarm is the Essential Commodities Index hitting…
South Korea just broke its own monthly current account surplus record for the second month in a row — hitting $49.73 billion in…
Apple's App Store quietly became a $26.8 billion economy inside South Korea alone in 2025 — more than double its size five years…
NITI Aayog has laid out a formal blueprint for turning India's caregiving workforce into a global export — backed by a proposed…
